Anthony Mastracchio

Title: Anthony Mastracchio: Innovator in PDE4 Inhibitors

Introduction

Anthony Mastracchio is a notable inventor based in Linden, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of PDE4 inhibitors. With a total of 2 patents, his work focuses on innovative solutions for various respiratory and inflammatory diseases.

Latest Patents

Mastracchio's latest patents include "Substituted 8-arylquinoline PDE4 inhibitors" and "Substituted 8-arylquinoline phosphodiesterase-4 inhibitors." The first patent describes 8-arylquinolines that contain a meta two-atom bridge to an optionally substituted phenyl or pyridyl group. These compounds are designed to treat conditions such as asthma, chronic bronchitis, chronic obstructive pulmonary disease, arthritis, and more. The second patent introduces novel substituted 8-arylquinolines with a substituent substituted-alkenyl group, which also serve as PDE4 inhibitors.

Career Highlights

Mastracchio is currently employed at Merck Frosst Canada & Co., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic options for patients suffering from various diseases.

Collaborations

Throughout his career, Mastracchio has collaborated with esteemed colleagues, including Denis Deschenes and Daniel Dube. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Anthony Mastracchio's contributions to the field of PDE4 inhibitors highlight his commitment to improving healthcare through innovative pharmaceutical solutions. His patents reflect a dedication to addressing significant medical challenges.